Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study – il AD (I... by Luigi Gargiulo, Luciano Ibba, Angela Alfano, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Francesca Barei, Anna G. Burroni, Stefano Caccavale, Piergiacomo Calzavara-Pinton, Maria Esposito, Maria C. Fargnoli, Silvia M. Ferrucci, Caterina Foti, Giampiero Girolomoni, Massimo Gola, Mario B. Guanti, Carlotta Gurioli, Manfredi Magliulo, Martina Maurelli, Pietro Morrone, Maria L. Musumeci, Maddalena Napolitano, Michela Ortoncelli, Cataldo Patruno, Bianca M. Piraccini, Elena Pezzolo, Simone Ribero, Mariateresa Rossi, Paola Savoia, Claudio Sciarrone, Benedetta Tirone, Marco Vaccino, Federica Veronese, Antonio Costanzo, Alessandra Narcisi

Subjects: Get full text

Oral abrocitinib in the treatment of granuloma annulare: a case report by Wenyan Liu, Weifeng Chen, Xin Tian, Yihui Yu, Junhui Zhu, Jingyao Liang, Xibao Zhang

Subjects: Get full text

Concurrent Refractory Atopic Dermatitis and Generalized Vitiligo Successfully Treated with Abrocitinib: A Case Report by Shao X, Pan X, Chen Y, Zhu Y, Chen S, Chen J

Subjects: Get full text

Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors by Elisabet Castañeda-Estévez, Cristina Vergara-Dangond, Martina Steiner, Maria Beatriz Paredes-Romero, Ana Esteban-Vázquez, Tatiana Cobo-Ibañez, Laura Trives-Folguera, Maria Liz Romero-Bogado, Isabel De La Cámara-Fernández, Patricia Richi-Alberti, Ana Acosta-Alfaro, Iría De la Osa-Subtil, Santiago Muñoz-Fernández

Subjects: “…JAK inhibitors…”
Get full text

Monocyte STAT1 phosphorylation and treatment response of JAK inhibitors in chronic nonbacterial osteomyelitis by Motoshi Sonoda, Keishiro Kinoshita, Nobutaka Harada, Sungyeon Park, Shunichi Adachi, Yutaro Yada, Katsuhide Eguchi, Toshifumi Fujiwara, Makiko Kido-Nakahara, Noriko Kinjo, Masataka Ishimura, Shouichi Ohga

Subjects: Get full text

Treatment Strategies Used in Treating Myelofibrosis: State of the Art by Massimo Martino, Martina Pitea, Annalisa Sgarlata, Ilaria Maria Delfino, Francesca Cogliandro, Anna Scopelliti, Violetta Marafioti, Simona Polimeni, Gaetana Porto, Giorgia Policastro, Giovanna Utano, Maria Pellicano, Giovanni Leanza, Caterina Alati

Subjects: Get full text

A Threefold Association Between Vitiligo and Alopecia Areata: Results from a Nationwide Case-control Observational Study by Yonit Wohl, Amir Bentov, Yarden Drutin, Annabel Maruani, Jacob Mashiah

Subjects: Get full text

Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study by Carlo A. Vignoli, Luigi Gargiulo, Luciano Ibba, Anna Balato, Mauro Barbareschi, Stefania Barruscotti, Giulia Bazzacco, Francesco Bellinato, Vittoria G. Bianchi, Valeria Boccaletti, Raffaele D. Caposiena Caro, Silvia M. Ferrucci, Alessandro Fraghì, Elisabetta Fulgione, Giuseppe Gallo, Paolo Gisondi, Isotta Giunipero di Corteranzo, Piergiorgio Malagoli, Angelo V. Marzano, Santo R. Mercuri, Diego Orsini, Pietro Quaglino, Simone Ribero, Antonio Costanzo, Alessandra Narcisi

Subjects: Get full text

Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis by Sihan Wang, Ziqian Xu, Xiaoxia Zhu, Xin Fan, Yingzhe Yu, Bingjiang Lin, Suling Xu

Subjects: Get full text

Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer by Karen Geoffroy, Victor Mullins-Dansereau, Kim Leclerc-Desaulniers, Mélissa Viens, Marie-Claude Bourgeois-Daigneault

Subjects: Get full text

Amenorrhea in an Adolescent Female as a Rare Adverse Event of Upadacitinib Treatment for Atopic Dermatitis by Teng Y, Tang Y, Fan Y, Tao X, Ding Y

Subjects: Get full text

Vascular synovial phenotype indicates poor response to JAK inhibitors in rheumatoid arthritis patients: a pilot study by Mengxia Liu, Pengcheng Liu, JianBin Li, Yiping Huang, Rui Wu

Subjects: Get full text

JAK inhibitors: a new choice for diabetes mellitus? by Mengjun Zhou, Qi Shen, Bo Li

Subjects: “…JAK inhibitors…”
Get full text

Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future? by Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

Subjects: “…JAK inhibitors…”
Get full text

A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents by Andrea Picchianti Diamanti, Concetta Panebianco, Valeria Di Gioia, Ilaria Anna Bellofatto, Simonetta Salemi, Roberta Di Rosa, Giorgio Sesti, Gabriele Nalli, Gerardo Salerno, Etta Finocchiaro, Bruno Laganà

Subjects: Get full text

JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia by Karoline Strobl, Jörg Klufa, Regina Jin, Lena Artner-Gent, Dana Krauß, Philipp Novoszel, Johanna Strobl, Georg Stary, Igor Vujic, Johannes Griss, Martin Holcmann, Matthias Farlik, Bernhard Homey, Maria Sibilia, Thomas Bauer

Subjects: Get full text

Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study by Boulos Haraoui, Majed Khraishi, Denis Choquette, Isabelle Fortin, Cassandra D. Kinch, Corina Galos, Patrice Roy, David Gruben, Julie Vaillancourt, John S. Sampalis, Edward C. Keystone

Subjects: Get full text

Case of recalcitrant amyopathic dermatomyositis treated with upadacitinib by Albert E. Zhou, MD, PhD, Maria Katsetos, BS, Jun Lu, MD, PhD

Subjects: Get full text

Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast by Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, Hector Chinoy, Roberto D’Alessandro, Federica Camarda, Luca Cantarini, Bruno Frediani, Giuliana Guggino, Lidia La Barbera

Subjects: Get full text

Evaluating the Efficacy and Safety of Baricitinib in Reducing COVID-19 Mortality: A Comprehensive Review of Clinical Evidence and Pharmacological Strategies by Paulina Klaudia Kwaśniewska, Patryk Graczyk, Anna Wilewska, Kinga Borowiec, Agnieszka Borowiec, Julia Biernikiewicz, Konstanty Alabrudziński, Milena Biernikiewicz, Bartosz Pomirski, Agata Pomirska

Subjects: Get full text